The Structural Proteins of Membrane Rafts, Caveolins and Flotillins, in Lung Cancer: More Than Just Scaffold Elements.


Journal

International journal of medical sciences
ISSN: 1449-1907
Titre abrégé: Int J Med Sci
Pays: Australia
ID NLM: 101213954

Informations de publication

Date de publication:
2023
Historique:
received: 06 07 2023
accepted: 25 08 2023
medline: 7 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: epublish

Résumé

Lung cancer is one of the most frequently diagnosed cancers worldwide. Due to its late diagnosis, it remains the leading cause of cancer-related deaths. Despite it is mostly associated to tobacco smoking, recent data suggested that genetic factors are of the highest importance. In this context, different processes meaningful for the development and progression of lung cancer such endocytosis, protein secretion and signal transduction, are controlled by membrane rafts. These highly ordered membrane domains contain proteins such as caveolins and flotillins, which were traditionally considered scaffold proteins but have currently been given a preponderant role in lung cancer. Here, we summarize current knowledge regarding the involvement of caveolins and flotillins in lung cancer from a molecular point of view.

Identifiants

pubmed: 37928877
doi: 10.7150/ijms.87836
pii: ijmsv20p1662
pmc: PMC10620868
doi:

Substances chimiques

flotillins 0
Caveolins 0
Membrane Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1662-1670

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

Traffic. 2004 Apr;5(4):265-75
pubmed: 15030568
J Biol Chem. 2018 Feb 2;293(5):1794-1809
pubmed: 29247004
Asian Pac J Cancer Prev. 2013;14(4):2311-5
pubmed: 23725133
Oncogene. 1999 Mar 11;18(10):1881-90
pubmed: 10086342
Front Surg. 2022 Mar 21;9:813123
pubmed: 35388363
Cell Signal. 2012 Jul;24(7):1390-7
pubmed: 22406084
Sci Rep. 2019 Dec 12;9(1):18970
pubmed: 31831780
Mol Oncol. 2016 Apr;10(4):610-24
pubmed: 26774881
J Lipid Res. 2020 May;61(5):611-635
pubmed: 33715811
Oncol Rep. 2018 Sep;40(3):1287-1296
pubmed: 30015970
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Res. 2004 Jun 15;64(12):4277-85
pubmed: 15205342
Biomolecules. 2019 Jul 29;9(8):
pubmed: 31362353
J Thorac Dis. 2017 Jul;9(7):E644-E645
pubmed: 28840034
Biochem Biophys Res Commun. 2018 Oct 2;504(2):434-439
pubmed: 30195491
FEBS Lett. 1999 Apr 9;448(2-3):221-30
pubmed: 10218480
CA Cancer J Clin. 2020 Aug 25;:
pubmed: 32964460
Oncol Rep. 2007 Jun;17(6):1279-90
pubmed: 17487380
Dev Dyn. 2006 Sep;235(9):2538-48
pubmed: 16736490
Cells. 2021 Apr 30;10(5):
pubmed: 33946345
Annu Rev Biophys Biomol Struct. 2004;33:269-95
pubmed: 15139814
Precis Clin Med. 2021 Dec 02;4(4):258-270
pubmed: 35692863
FEBS Lett. 1998 Oct 9;436(3):403-10
pubmed: 9801158
Biochem J. 2005 Apr 15;387(Pt 2):309-14
pubmed: 15537390
Annu Rev Physiol. 2015;77:453-74
pubmed: 25668024
J Lipid Res. 2006 Jul;47(7):1597-8
pubmed: 16645198
J Biol Chem. 1998 Mar 6;273(10):5419-22
pubmed: 9488658
Methods Mol Biol. 2021;2187:147-186
pubmed: 32770506
Tumour Biol. 2017 Feb;39(2):1010428317694311
pubmed: 28229621
J Biol Chem. 2002 Oct 11;277(41):38772-80
pubmed: 12138116
BMC Cancer. 2019 Mar 12;19(1):222
pubmed: 30866866
Oncoimmunology. 2019 Jun 24;8(10):e1629260
pubmed: 31646073
Aging (Albany NY). 2019 Apr 12;11(7):2138-2150
pubmed: 30981205
Med Oncol. 2015 Jul;32(7):207
pubmed: 26094077
Cell Rep. 2013 Jul 25;4(2):238-47
pubmed: 23850288
Immunity. 2003 May;18(5):655-64
pubmed: 12753742
Oncotarget. 2017 Feb 14;8(7):12211-12224
pubmed: 28099944
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Cell Sci. 2005 Mar 15;118(Pt 6):1099-102
pubmed: 15764592
Mol Cell. 2014 Aug 21;55(4):604-14
pubmed: 25087872
Redox Biol. 2022 Jun;52:102304
pubmed: 35413643
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
Signal Transduct Target Ther. 2020 Oct 9;5(1):214
pubmed: 33033232
Cancer Cell Int. 2019 Jun 28;19:171
pubmed: 31297035
Am J Physiol Cell Physiol. 2005 Mar;288(3):C494-506
pubmed: 15692148
Cancer Cell. 2014 Nov 10;26(5):738-53
pubmed: 25517751
PLoS One. 2015 Jul 10;10(7):e0132190
pubmed: 26161893
Cell. 2003 Nov 14;115(4):377-88
pubmed: 14622593
Mol Cell. 2013 Mar 28;49(6):1083-96
pubmed: 23395002
J Proteomics. 2012 Dec 21;77:202-14
pubmed: 22982323
J Clin Invest. 2002 Sep;110(5):597-603
pubmed: 12208858
Mol Cancer. 2017 Jan 9;16(1):5
pubmed: 28069000
Transl Res. 2017 Nov;189:76-92
pubmed: 28644958
Exp Cell Res. 2010 Jun 10;316(10):1748-62
pubmed: 20153318
Trends Cell Biol. 2021 Feb;31(2):119-129
pubmed: 33248874
Nat Cell Biol. 1999 Jun;1(2):98-105
pubmed: 10559881
Eur J Cancer. 2021 Jul;151:94-105
pubmed: 33975060
Cancer Res. 2014 Nov 15;74(22):6452-62
pubmed: 25269481
J Biol Chem. 1998 Jan 9;273(2):1150-7
pubmed: 9422781
Front Oncol. 2020 Dec 07;10:537120
pubmed: 33425713
Front Oncol. 2022 Jan 10;11:792635
pubmed: 35083149
Biochem Biophys Res Commun. 1999 Feb 24;255(3):580-6
pubmed: 10049753
Int J Radiat Biol. 2008 Mar;84(3):177-89
pubmed: 18300018
Cell Death Differ. 2014 Jun;21(6):864-75
pubmed: 24488099
Nucleic Acids Res. 2019 Jan 8;47(D1):D459-D463
pubmed: 30329070
Cells. 2022 Apr 28;11(9):
pubmed: 35563790
Int Rev Cell Mol Biol. 2010;282:135-63
pubmed: 20630468
Int J Clin Exp Pathol. 2015 Jan 01;8(1):601-7
pubmed: 25755751
Br J Cancer. 2020 Oct;123(8):1289-1301
pubmed: 32684624
J Biol Chem. 2004 Jun 11;279(24):25574-81
pubmed: 15067006
Curr Biol. 2011 Apr 26;21(8):681-6
pubmed: 21497090
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Cancer Cell Int. 2014 Jun 14;14:52
pubmed: 24955034
J Exp Med. 2019 Sep 2;216(9):2202-2220
pubmed: 31235510
J Cell Physiol. 2020 Feb;235(2):1197-1208
pubmed: 31270811
Front Cell Dev Biol. 2022 Mar 23;10:833663
pubmed: 35399533
PLoS One. 2017 May 31;12(5):e0178515
pubmed: 28562687
Int Rev Cytol. 2006;252:1-69
pubmed: 16984815
EMBO J. 2003 Jun 16;22(12):3015-26
pubmed: 12805216
J Obstet Gynaecol Res. 2004 Feb;30(1):53-8
pubmed: 14718022
Annu Rev Cell Dev Biol. 1998;14:111-36
pubmed: 9891780
Mol Cancer. 2016 Nov 16;15(1):71
pubmed: 27852311
Aging (Albany NY). 2020 Jan 4;12(1):462-480
pubmed: 31901898
Asian J Surg. 2022 Jun;45(6):1338-1340
pubmed: 35249784
J Cell Physiol. 2019 Aug;234(10):17100-17112
pubmed: 30912122
Phytomedicine. 2019 May;58:152888
pubmed: 30901662
Front Genet. 2022 Jul 22;13:933009
pubmed: 35938010
Am J Pathol. 2001 Nov;159(5):1635-43
pubmed: 11696424
Future Oncol. 2010 Apr;6(4):491-4
pubmed: 20373862
Expert Rev Respir Med. 2019 Mar;13(3):291-300
pubmed: 30686114
Oncotarget. 2017 Oct 19;8(60):101899-101910
pubmed: 29254212
Biomed Pharmacother. 2012 Jun;66(4):242-8
pubmed: 22564243
Onco Targets Ther. 2022 Jul 09;15:761-769
pubmed: 35847380
Prostate. 2001 Feb 15;46(3):249-56
pubmed: 11170154
J Surg Oncol. 2013 Apr;107(5):555-9
pubmed: 22961206
Semin Cell Dev Biol. 1998 Oct;9(5):503-9
pubmed: 9835637
Dev Dyn. 2009 Sep;238(9):2103-14
pubmed: 19191220
Hypertension. 2021 Aug;78(2):270-281
pubmed: 34176282
Science. 2010 Jan 1;327(5961):46-50
pubmed: 20044567
Cancer Metastasis Rev. 2020 Jun;39(2):361-374
pubmed: 32297092
Am J Pathol. 2011 May;178(5):2236-51
pubmed: 21514437
Mol Biol Cell. 2009 Aug;20(16):3751-62
pubmed: 19553470
Acta Biochim Biophys Sin (Shanghai). 2020 Oct 19;52(10):1148-1155
pubmed: 33085760
Ageing Res Rev. 2020 Sep;62:101116
pubmed: 32554058
Cardiovasc Res. 2006 Apr 1;70(1):42-9
pubmed: 16412403
Int J Mol Med. 2006 Sep;18(3):489-95
pubmed: 16865235
Am J Pathol. 2002 Nov;161(5):1647-56
pubmed: 12414512
Anticancer Res. 2012 Feb;32(2):483-90
pubmed: 22287735
Transl Oncol. 2022 Apr;18:101364
pubmed: 35168143
Cancers (Basel). 2022 Jun 10;14(12):
pubmed: 35740528
Cell. 1992 Feb 21;68(4):673-82
pubmed: 1739974
J Cancer. 2019 May 21;10(10):2312-2318
pubmed: 31258734
J Biol Chem. 2010 Dec 10;285(50):38832-40
pubmed: 20923773
Tumour Biol. 2016 Sep;37(9):12713-12723
pubmed: 27448302
Thorac Cancer. 2019 Apr;10(4):909-917
pubmed: 30838797
Cell Prolif. 2022 Jan;55(1):e13167
pubmed: 34939255
J Thorac Dis. 2013 Oct;5 Suppl 5:S479-90
pubmed: 24163741
Curr Protein Pept Sci. 2011 Dec;12(8):725-35
pubmed: 22329548

Auteurs

Ana Karina Saldaña-Villa (AK)

Department of Molecular Biomedicine and Translational Research, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas". Mexico City, Mexico.

Roberto Lara-Lemus (R)

Department of Molecular Biomedicine and Translational Research, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas". Mexico City, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH